文献速递瓣膜外科

经导管瓣膜直接植入治疗二尖瓣环钙化:多中心研究

Direct Implantation of Transcatheter Valve in Mitral Annular Calcification: A Multicenter Study.
PubMed 文献 · Ann Thorac Surg · 2024-10-11

30天死亡2例,1年死亡4例(均为非心脏原因),1例术后卒中,无左室流出道梗阻,平均跨瓣压差4.42±4.40 mmHg。结论提示该策略可用于高危无法常规手术患者。

要点

  • 严重环周二尖瓣环钙化患者经心房直接植入经导管瓣膜技术可行。
  • 30天死亡率9%,1年死亡率18%,适用于无法常规手术的高危患者。
  • 术后无左室流出道梗阻,多数患者无或微量瓣周漏。

核心结论

  • 严重二尖瓣环钙化患者直接植入经导管瓣膜可能是合理选择,但应限于无法常规策略的高危患者。

主要发现

  • 30天死亡2例,1年非心脏原因死亡4例,术后卒中1例。

临床怎么用

  • 对于严重环周二尖瓣环钙化且无法耐受常规手术的高危患者,可考虑经心房直接植入经导管瓣膜。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Mitral valve replacement in the setting of severe annular calcification (MAC) is associated with high morbidity and mortality. Direct surgical implantation of a transcatheter heart valve (THV) through a transatrial approach is a strategy to mitigate surgical risk. This study reports the perioperative and 1-year outcomes of mitral valve replacement using a THV in patients with severe circumferential MAC at 3 Canadian centers. METHODS: Charts were reviewed between January 1, 2018 and September 30, 2023 to identify patients with severe circumferential MAC who had undergone direct implantation of a THV. Primary outcomes were 30-day mortality, debilitating stroke, and 1-year mortality. Secondary outcomes included left ventricular outflow tract obstruction, degree of paravalvular leak (PVL), transvalvular mean pressure gradient, and length of stay. RESULTS: Twenty-two patients at the 3 centers underwent direct implantation of a THV. Nineteen patients were female, with mean age of 70.41 ± 9.33 years. A THV was successfully implanted in all patients. There were 2 deaths at 30 days. Four patients died of noncardiac causes at 1 year, and 1 patient had a postoperative stroke. Seventeen (77%) patients had no PVL or trace PVL, 4 had mild PVL, and 1 patient had mild-moderate PVL. The mean transvalvular gradient was 4.42 ± 4.40 mm Hg. There were no cases of left ventricular outflow tract obstruction. CONCLUSIONS: Direct deployment of a THV in patients with severe MAC may be a reasonable option. Thirty-day and 1-year mortality rates of 9% and 18%, respectively, suggest that this approach should be reserved for high-risk patients who are not able to undergo conventional strategies.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Fatehi Hassanabad A, Rabbani M, Tam DY, et al. Direct Implantation of Transcatheter Valve in Mitral Annular Calcification: A Multicenter Study. Ann Thorac Surg. 2024. PMID: 39396669. doi:10.1016/j.athoracsur.2024.09.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。